Jump to main content
Jump to site search

Issue 4, 2012
Previous Article Next Article

DNA binding and cytotoxicity of fluorescent curcumin-based Zn(ii) complexes

Author affiliations

Abstract

Two new heteroleptic pentacoordinated Zn(II) complexes (1 and 2) containing 4,4′-disubstituted 2,2′-bipyridines as the main ligand and curcumin (curc) as an ancillary ligand have been synthesized, spectroscopically and structurally characterized, and tested in vitro towards different human cancer cell lines. While the nitrogen ligands are almost inactive, Zn(II) curc derivatives 1 and 2 show promising and selective anticancer properties. In particular the curc Zn(II) complex 1 shows the strongest growth inhibition in all cell lines, being even more effective than the pure curc in the LAN-5 neuroblastoma cell line. Furthermore, the curc moiety makes the complexes 1 and 2 fluorescent, a feature enabling investigation of their interaction with DNA through a new optical method previously tested with the reference fluorescent intercalator ethidium bromide. This analysis demonstrates that the interaction mode of curc, 1 and 2 with DNA in the double helix favors their alignment perpendicular to the DNA axis, suggesting a partial inter-base intercalation of these Zn(II) complexes.

Graphical abstract: DNA binding and cytotoxicity of fluorescent curcumin-based Zn(ii) complexes

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Oct 2011, accepted on 29 Dec 2011 and first published on 04 Jan 2012


Article type: Concise Article
DOI: 10.1039/C2MD00261B
Med. Chem. Commun., 2012,3, 462-468

  •   Request permissions

    DNA binding and cytotoxicity of fluorescent curcumin-based Zn(II) complexes

    D. Pucci, T. Bellini, A. Crispini, I. D'Agnano, P. F. Liguori, P. Garcia-Orduña, S. Pirillo, A. Valentini and G. Zanchetta, Med. Chem. Commun., 2012, 3, 462
    DOI: 10.1039/C2MD00261B

Search articles by author

Spotlight

Advertisements